GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Book Value per Share History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Book NAV/Share(Rs) | 313.28 | 277.46 | 335.13 | 321.45 | 249.60 |
What is the latest Book Value per Share ratio of GLENMARK PHARMACEUTICALS ?
| Year | Book Value per Share |
|---|---|
| Mar2025 | 313.28 |
| Mar2024 | 277.46 |
| Mar2023 | 335.13 |
| Mar2022 | 321.45 |
| Mar2021 | 249.60 |
How is Book Value per Share of GLENMARK PHARMACEUTICALS Trending?
| Years | Book Value per Share | % Change | |
|---|---|---|---|
| Mar2025 | 313.28 | 12.91 | |
| Mar2024 | 277.46 | -17.21 | |
| Mar2023 | 335.13 | 4.26 | |
| Mar2022 | 321.45 | 28.79 | |
| Mar2021 | 249.6 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Book Value per Share ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹60,792.9 Cr | -0.9% | -10.4% | 30.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.9% |
-10.4% |
30.4% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses